Delivery Order SPE2DB20D1100-SPE2DB25FB8Y2
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,638.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Lyrica 25 mg capsules, a prescription medication, with a period of performance through May 1, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $3,650.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order (SPE2DB20D1100|SPE2DB25FB9S6) for the supply of Lyrica 50 mg capsules, a medication used to treat nerve pain. The contract has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,281.97 firm fixed-price delivery order contract covers the supply of LYRICA 100 mg capsules, a prescription medication primarily used to treat neuropathic pain. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC0L5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 25 mg capsules, a prescription medication, with a ceiling value of $3,139.12. The contract is a Firm Fixed Price Delivery Order with a performance period extending to May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,549.53 firm fixed-price delivery order is for 4,567,888,073 units of the drug Lyrica 150 mg capsules. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,571.40 firm-fixed-price delivery order is for 4,566,790,170 Lyrica 100 mg capsules in quantities of 90 per bottle. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,693.70 firm fixed-price delivery order is for the supply of 90 capsules of the medication Lyrica 50 mg. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,177.02, is a delivery order to supply 4,567,887,180 units of Lyrica 25 mg capsules. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen has a significant Indefinite Delivery...
This federal contract award (SPE2DB20D3103|SPE2DB24FL9K3) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.40 firm fixed-price delivery order is for the provision of Lyrica 50 mg capsules and has an ultimate completion date of December 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,057.14 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to provide Lyrica 75 mg capsules. The contract has a period of performance through February 7, 2024 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...